Inventor · disambiguated record
John A. Mccauley
Also filed as: MCCAULEY JOHN · MCCAULEY JOHN A
50 granted patents·22 pending applications·462 citations·filing 1994–2023
98Inventor score
Files withMERCK SHARP & DOHME29MERCK & CO INC11MERCK SHARP & DOHME LLC9MCCAULEY JOHN A7LIVERTON NIGEL J4
Top patents by PatentIndex Score
72 records- 0197US7470664B2HCV NS3 protease inhibitorsMERCK & CO INC·Filed 2006·Granted Dec 30, 2008·81 cites·40 claims
- 0296US7973040B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2009·Granted Jul 5, 2011·40 cites·12 claims
- 0395US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 0494US8080654B2Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitorsHARPER STEVEN·Filed 2011·Granted Dec 20, 2011·36 cites·8 claims
- 0593US10479801B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Nov 19, 2019·7 cites·39 claims
- 0691US9090661B2Inhibitors of hepatitis C virus replicationMERCK SHARP & DOHME·Filed 2014·Granted Jul 28, 2015·18 cites·16 claims
- 0791US8216999B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2008·Granted Jul 10, 2012·26 cites·18 claims
- 0891US7879797B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Feb 1, 2011·15 cites·16 claims
- 0990US6316474B12-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Nov 13, 2001·43 cites·13 claims
- 1089US8278322B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2006·Granted Oct 2, 2012·10 cites·40 claims
- 1187US8461107B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2009·Granted Jun 11, 2013·12 cites·26 claims
- 1287US7592360B23-fluoro-piperidines as NMDA/NR2B antagonistsMERCK & CO INC·Filed 2004·Granted Sep 22, 2009·18 cites·32 claims
- 1386US11884683B2Tricyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jan 30, 2024·4 cites·17 claims
- 1486US8377874B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·9 cites·13 claims
- 1585US8828930B2Hepatitis C virus NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2010·Granted Sep 9, 2014·8 cites·6 claims
- 1685US8309540B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2007·Granted Nov 13, 2012·9 cites·24 claims
- 1784US5621108AProcesses and intermediates for preparing macrocyclesUNIV PENNSYLVANIA·Filed 1994·Granted Apr 15, 1997·25 cites·10 claims
- 1883US7053089B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 30, 2006·13 cites·40 claims
- 1982US10829499B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Nov 10, 2020·1 cites·14 claims
- 2082US8927569B2Macrocyclic compounds as antiviral agentsHARPER STEVEN·Filed 2008·Granted Jan 6, 2015·8 cites·17 claims
- 2181US12338219B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 24, 2025·1 cites·16 claims
- 2281US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 2378US7217716B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 15, 2007·8 cites·9 claims
- 2478US6291499B12-cyclohexyl benzimidazole NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Sep 18, 2001·12 cites·14 claims
- 2577US7259157B2N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B AntagonistsMERCK & CO INC·Filed 2002·Granted Aug 21, 2007·12 cites·16 claims
- 2676US12350270B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 8, 2025·1 cites·52 claims
- 2772US9315475B2HIV protease inhibitorsBEAULIEU CHRISTIAN·Filed 2013·Granted Apr 19, 2016·5 cites·23 claims
- 2871US9440952B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Sep 13, 2016·1 cites·19 claims
- 2970US10138255B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 27, 2018·1 cites·19 claims
- 3070US9840478B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·13 claims
- 3169US2021040096A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3267US11358711B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted Jun 14, 2022·0 cites·14 claims
- 3364US9737545B2HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 3464US2024228535A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3562US11958864B2Tetracyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Apr 16, 2024·0 cites·19 claims
- 3662US9233977B2Leucine-rich repeat kinase enzyme activityMCCAULEY JOHN A·Filed 2011·Granted Jan 12, 2016·1 cites·15 claims
- 3762US6495561B22-cyclohexyl imidazopyridine NMDA/NR2B antagonistsMERCK & CO INC·Filed 2001·Granted Dec 17, 2002·1 cites·5 claims
- 3862US6380205B12-cyclohexyl quinazoline NMDA/NR2B antagonistsMERCK & CO INC·Filed 2001·Granted Apr 30, 2002·1 cites·5 claims
- 3962US2019322666A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 4060US2025230161A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4160US2025066379A1Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4259US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4358US2018099967A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 4455US9738661B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Aug 22, 2017·0 cites·7 claims
- 4555US2024018145A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4655US2010099695A1HCV NS3 Protease InhibitorsLIVERTON NIGEL J·Filed 2007·Application pending·0 cites
- 4754US2017190701A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsYU TAO·Filed 2016·Application pending·0 cites
- 4852US10786488B2Substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 29, 2020·0 cites·15 claims
- 4952US7452893B24-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonistsMERCK & CO INC·Filed 2004·Granted Nov 18, 2008·0 cites·9 claims
- 5051US2011243844A1Sulfonamide derivative metabotropic glutamate r4 ligandsMCCAULEY JOHN A·Filed 2009·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John A. Mccauley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →